
Tegoyes 4.35mg/11.8mg/15mg Capsule
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Gimeracil (4.35mg) + Oteracil (11.8mg) + Tegafur (15mg)
Overview Tegoyes 4.35mg/11.8mg/15mg Capsule
Triomphex capsules (4.35mg/11.8mg/15mg) are a combined medication employed in gastric cancer management. This therapy can be administered independently or incorporated into multi-drug chemotherapy regimens. Its mechanism involves disrupting cancerous cell proliferation, ultimately leading to their demise. Triomphex capsules should be ingested with water, ideally at least an hour before or after meals. Dosage and frequency are determined by your physician, contingent upon your specific condition and may be adjusted. Adhere strictly to prescribed instructions; improper usage or overdose can result in severe adverse reactions. While therapeutic benefits might not be immediately apparent (requiring weeks or months), discontinue use only under medical supervision. Frequent adverse effects include myelosuppression, acute kidney failure, diarrhea, dehydration, electrolyte imbalances, and tear duct complications. Report any concerning symptoms to your doctor; mitigation strategies may be available. Prior to commencing treatment, disclose any pre-existing hematological, renal, hepatic, or respiratory conditions. This medication diminishes blood cell counts, increasing infection vulnerability. Regular blood tests monitoring blood cell levels, alongside kidney, liver, and heart function, are mandatory throughout treatment. Both partners should utilize reliable contraception during therapy to prevent conception.
Primary Ingredients of Tegoyes 4.35mg/11.8mg/15mg Capsule
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Tegoyes 4.35mg/11.8mg/15mg Capsule
Managing Gastric Cancer
Major Benefits of Tegoyes 4.35mg/11.8mg/15mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Administer Tegoyes 4.35mg/11.8mg/15mg Capsules on an empty stomach.
Common Side effects of Tegoyes 4.35mg/11.8mg/15mg Capsule:
- Bone marrow suppression
- Acute renal failure
- Diarrhea
- Dehydration
- Electrolyte imbalance
- Lacrimation (flow of tears)
How to use Tegoyes 4.35mg/11.8mg/15mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Administer Tegoyes 4.35mg/11.8mg/15mg Capsules on an empty stomach.
How Tegoyes 4.35mg/11.8mg/15mg Capsule works:
Each Tegoyes 4.35mg/11.8mg/15mg capsule unites three anticancer agents. Tegafur transforms into the active 5-fluorouracil (5-FU), disrupting DNA and RNA synthesis and function to curb cancer cell proliferation. Gimeracil safeguards 5-FU from degradation, thus sustaining potent anti-cancer levels. Oteracil mitigates 5-FU's gastrointestinal side effects.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tegoyes 4.35mg/11.8mg/15mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Tegoyes 4.35mg/11.8mg/15mg capsules during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in life-threatening emergencies where potential benefits outweigh the dangers. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Tegoyes 4.35mg/11.8mg/15mg capsules are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Tegoyes 4.35mg/11.8mg/15mg Capsules, which can produce side effects such as fatigue, dizziness, blurred vision, and nausea, particularly when co-administered with cisplatin.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Tegoyes 4.35mg/11.8mg/15mg Capsules. Dosage modification for Tegoyes 4.35mg/11.8mg/15mg Capsules may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Tegoyes 4.35mg/11.8mg/15mg capsules may be administered to patients with hepatic impairment without modification to the prescribed dosage.
What if you forget to take Tegoyes 4.35mg/11.8mg/15mg Capsule :
Should you forget a Tegoyes 4.35mg/11.8mg/15mg Capsule dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tegoyes 4.35mg/11.8mg/15mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
